Mirae Asset Global Investments’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $153K | Buy |
1,116
+152
| +16% | +$20.9K | ﹤0.01% | 1079 |
|
2025
Q1 | $177K | Buy |
964
+6
| +0.6% | +$1.1K | ﹤0.01% | 1064 |
|
2024
Q4 | $153K | Sell |
958
-81
| -8% | -$12.9K | ﹤0.01% | 1086 |
|
2024
Q3 | $184K | Buy |
1,039
+186
| +22% | +$32.9K | ﹤0.01% | 1095 |
|
2024
Q2 | $156K | Sell |
853
-11,148
| -93% | -$2.04M | ﹤0.01% | 1087 |
|
2024
Q1 | $1.19M | Sell |
12,001
-1,483
| -11% | -$147K | ﹤0.01% | 1439 |
|
2023
Q4 | $1.67M | Buy |
13,484
+969
| +8% | +$120K | ﹤0.01% | 1339 |
|
2023
Q3 | $1.45M | Buy |
12,515
+566
| +5% | +$65.7K | ﹤0.01% | 1335 |
|
2023
Q2 | $1.4M | Sell |
11,949
-563
| -4% | -$65.9K | ﹤0.01% | 1392 |
|
2023
Q1 | $1M | Buy |
12,512
+2,311
| +23% | +$185K | ﹤0.01% | 1546 |
|
2022
Q4 | $808K | Buy |
+10,201
| New | +$808K | ﹤0.01% | 1618 |
|